Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R Tan

Showing results (561-570 of 640) with videos related to

Pageof 64
Sort By:
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignanciesKian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, et al.
Journal of Multidisciplinary Healthcare|March 19, 2015
Protocol for audit of current Filipino practice in rehabilitation of stroke inpatientsConsuelo B Gonzalez-Suarez, Janine Margarita R Dizon, Karen Grimmer, et al.
JAMA Network Open|February 1, 2022
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal CancerRe-I Chin, Ebunoluwa E Otegbeye, Kylie H Kang, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 9, 2017
Homoepitaxial Growth of Large-Scale Highly Organized Transition Metal Dichalcogenide PatternsJianyi Chen, Xiaoxu Zhao, Gustavo Grinblat, et al.
The Lancet. Oncology|December 28, 2020
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 studyAntoinette R Tan, Seock-Ah Im, André Mattar, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Biochemical Pharmacology|November 28, 2017
α<sub>1A</sub>-Adrenoceptors activate mTOR signalling and glucose uptake in cardiomyocytesMasaaki Sato, Bronwyn A Evans, Anna L Sandström, et al.
Clean Technologies and Environmental Policy|August 25, 2020
Process integration for emerging challenges: optimal allocation of antivirals under resource constraintsC L Sy, K B Aviso, C D Cayamanda, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignanciesPaula M Fracasso, Joel Picus, Jonathan D Wildi, et al.
Pageof 64

Showing results (561-570 of 640) with videos related to

Sort By:
Pageof 64
European Journal of Cancer (Oxford, England : 1990)|July 13, 2021
Phase 1 study combining alisertib with nab-paclitaxel in patients with advanced solid malignanciesKian-Huat Lim, Mateusz Opyrchal, Abhi Acharya, et al.
Journal of Multidisciplinary Healthcare|March 19, 2015
Protocol for audit of current Filipino practice in rehabilitation of stroke inpatientsConsuelo B Gonzalez-Suarez, Janine Margarita R Dizon, Karen Grimmer, et al.
JAMA Network Open|February 1, 2022
Cost-effectiveness of Total Neoadjuvant Therapy With Short-Course Radiotherapy for Resectable Locally Advanced Rectal CancerRe-I Chin, Ebunoluwa E Otegbeye, Kylie H Kang, et al.
British Journal of Cancer|June 9, 2005
Phase I study of pegylated liposomal doxorubicin and the multidrug-resistance modulator, valspodarP M Fracasso, K A Blum, M K Ma, et al.
Advanced Materials (Deerfield Beach, Fla.)|December 9, 2017
Homoepitaxial Growth of Large-Scale Highly Organized Transition Metal Dichalcogenide PatternsJianyi Chen, Xiaoxu Zhao, Gustavo Grinblat, et al.
The Lancet. Oncology|December 28, 2020
Fixed-dose combination of pertuzumab and trastuzumab for subcutaneous injection plus chemotherapy in HER2-positive early breast cancer (FeDeriCa): a randomised, open-label, multicentre, non-inferiority, phase 3 studyAntoinette R Tan, Seock-Ah Im, André Mattar, et al.
Breast Cancer Research and Treatment|September 20, 2022
Molecular characterization of ESR1 variants in breast cancerArielle L Heeke, Andrew Elliott, Rebecca Feldman, et al.
Biochemical Pharmacology|November 28, 2017
α<sub>1A</sub>-Adrenoceptors activate mTOR signalling and glucose uptake in cardiomyocytesMasaaki Sato, Bronwyn A Evans, Anna L Sandström, et al.
Clean Technologies and Environmental Policy|August 25, 2020
Process integration for emerging challenges: optimal allocation of antivirals under resource constraintsC L Sy, K B Aviso, C D Cayamanda, et al.
Cancer Chemotherapy and Pharmacology|April 17, 2008
Phase 1 and pharmacokinetic study of weekly docosahexaenoic acid-paclitaxel, Taxoprexin, in resistant solid tumor malignanciesPaula M Fracasso, Joel Picus, Jonathan D Wildi, et al.
Pageof 64